[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343013-105":59,"doc-detail-343013-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","stochasticity-of-anticancer-mechanisms-underlying-clinical-effectiveness-of-vorinostat-review-article","Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat - Review article","","The Food and Drug Administration (FDA) has approved vorinostat, also called Zolinza®, for its effectiveness in fighting cancer. This drug is a suberoyl-anilide hydroxamic acid belonging to histone deacetylase inhibitor (HDACi) class, promoting acetylated histone accumulation and restoring normal gene expression. Evidence shows vorinostat induces histone acetylation and cytotoxicity across cancer cell lines, alters cell-cycle and apoptotic regulators, and modulates immune signaling (e.g., PD-L1, IFN-γR1), while affecting protein degradation, ER function, arrest, apoptosis, microenvironment remodeling, and angiogenesis inhibition.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stochasticity-of-anticancer-mechanisms-underlying-clinical-effectiveness-of-vorinostat-review-article/343013/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stochasticity-of-anticancer-mechanisms-underlying-clinical-effectiveness-of-vorinostat-review-article/343013.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does vorinostat play in cancer therapy?","Question",{"text":113,"@type":114},"Vorinostat is an FDA-approved HDAC inhibitor used to improve clinical effectiveness against cancer by promoting acetylated histone accumulation and restoring gene expression.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does vorinostat affect cancer cells at the molecular level?",{"text":118,"@type":114},"It induces histone acetylation and cytotoxicity, increases p21 cell cycle protein levels, enhances pro-apoptotic factors, and reduces anti-apoptotic factors.",{"name":120,"@type":111,"acceptedAnswer":121},"Besides apoptosis, what other pathways can vorinostat influence?",{"text":122,"@type":114},"It can regulate immune responses through PD-L1 and IFN-γR1 expression and may impact proteasome/aggresome degradation, endoplasmic reticulum function, cell-cycle arrest, tumor microenvironment remodeling, and angiogenesis inhibition.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343013,1790634282,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Heliyon 10 (2024) e33052  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Review article\u003Cbr>Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat\u003Cbr>Nasreddine El Omaria , Asaad Khalid b, c, ** , Hafiz A. Makeend , Hassan A. Alhazmib, e , Mohammed Albrattye, Syam Mohan b, f, Ching Siang Tang, * , Long Chiau Mingh , Jack Bee Chookh, *** , Abdelhakim Bouyahya i\u003Cbr>a High Institute of Nursing Professions and Health Techniques of Tetouan, Tetouan, Morocco\u003Cbr>b Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box 114, Postal Code 45142, Jazan, Saudi Arabia c Medicinal and Aromatic Plants Research Institute, National Center for Research, P.O. Box: 2424, Khartoum, 11111, Sudan d Pharmacy Practice Research Unit, Clinical Pharmacy Department, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia\u003Cbr>e Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, P.O. Box 114, Postal Code 45142, Jazan, Saudi Arabia\u003Cbr>f School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India g School of Pharmacy, KPJ Healthcare University, Nilai, Malaysia\u003Cbr>h School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia\u003Cbr>i Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, 10106, Morocco |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Cancer\u003Cbr>Oncology\u003Cbr>Human and disease Medicine\u003Cbr>Cell death\u003Cbr>Clinical efficacy Apoptosis Epigenetic pathways |  | The Food and Drug Administration (FDA) has approved vorinostat, also called Zolinza®, for its effectiveness in fighting cancer. This drug is a suberoyl-anilide hydroxamic acid belonging to the class of histone deacetylase inhibitors (HDACis). Its HDAC inhibitory potential allows it to accumulate acetylated histones. This, in turn, can restore normal gene expression in cancer cells and activate multiple signaling pathways. Experiments have proven that vorinostat induces histone acetylation and cytotoxicity in many cancer cell lines, increases the level of p21 cell cycle proteins, and enhances pro-apoptotic factors while decreasing anti-apoptotic factors. Additionally, it regulates the immune response by up-regulating programmed death-ligand 1 (PD-L1) and interferon gamma receptor 1 (IFN-γR1) expression, and can impact proteasome and/or aggresome degradation, endoplasmic reticulum function, cell cycle arrest, apoptosis, tumor microenvironment remodeling, and angiogenesis inhibition. In this study, we sought to elucidate the precise molecular mechanism by which Vorinostat inhibits HDACs. A deeper understanding of these mechanisms could improve our understanding of cancer cell abnormalities and provide new therapeutic possibilities for cancer treatment. |\n\n* Corresponding author. School of Pharmacy, KPJ Healthcare University, 71800, Nilai, Malaysia.  \n** Corresponding author. Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box 114, Postal Code 45142, Jazan, Saudi Arabia.  \n*** Corresponding author.  \nE-mail addresses: [akahmed@jazanu.edu.sa](akahmed@jazanu.edu.sa) (A. Khalid), [tcsiang@kpju.edu.my](tcsiang@kpju.edu.my) (C.S. Tan), [jackbeec@sunway.edu.my](jackbeec@sunway.edu.my) (J.B. Chook).  \n[https://doi.org/10.1016/j.heliyon.2024.e33052](https://doi.org/10.1016/j.heliyon.2024.e33052)  \nReceived 21 January 2024; Received in revised form 7 June 2024; Accepted 13 June 2024 Available online 18 June 2024  \n2405-8440/© 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n1. Introduction  \nCancer disease is characterized by high complexity, involving a variety of risk fa","cbCaikUAWoArTRxz","https://ap.wps.com/l/cbCaikUAWoArTRxz","pdf",2232690,25,"English","# Introduction\n## Vorinostat and HDAC inhibition in cancer","[{\"question\":\"What role does vorinostat play in cancer therapy?\",\"answer\":\"Vorinostat is an FDA-approved HDAC inhibitor used to improve clinical effectiveness against cancer by promoting acetylated histone accumulation and restoring gene expression.\"},{\"question\":\"How does vorinostat affect cancer cells at the molecular level?\",\"answer\":\"It induces histone acetylation and cytotoxicity, increases p21 cell cycle protein levels, enhances pro-apoptotic factors, and reduces anti-apoptotic factors.\"},{\"question\":\"Besides apoptosis, what other pathways can vorinostat influence?\",\"answer\":\"It can regulate immune responses through PD-L1 and IFN-γR1 expression and may impact proteasome/aggresome degradation, endoplasmic reticulum function, cell-cycle arrest, tumor microenvironment remodeling, and angiogenesis inhibition.\"}]","Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat - Review article | PDF",1790049429,63,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/590fc035750fe48849dbf9775a4a1b6b.webp",983,1341,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84f98e030799628ce0098818ad31d2b8.webp",982,1340,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf36f145862c5592b24db357af92508d.webp",981,1338,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f6f0dd4ceddefe0b2638080d494fe8f.webp",980,1337]